Celularity (CELU) Enterprise Value (2018 - 2025)
Celularity (CELU) posted quarterly Enterprise Value of -$6.2 million for Q4 2025, down 736.72% year-over-year from $969812.7 in Q4 2024, and down 5045.83% quarter-over-quarter from -$120000.0 in Q3 2025.
Celularity (CELU) Enterprise Value (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Enterprise Value for 8 consecutive years, with -$6.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value fell 736.72% year-over-year to -$6.2 million; the TTM figure through Dec 2025 stood at -$6.2 million (down 736.72% YoY), while the FY2025 annual figure was -$6.2 million, down 736.72% from the prior year.
- Enterprise Value declined to -$6.2 million in Q4 2025 per CELU's latest filing, from -$120000.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$211.0 in Q2 2021 and bottomed at -$73.3 million in Q3 2021.
- Historically, Enterprise Value has averaged -$13.8 million across 5 years, with a median of -$1.4 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 18007482.94% — and 2023, when it soared 99.36%.
- Celularity's Enterprise Value stood at -$37.2 million in 2021, then jumped by 62.5% to -$14.0 million in 2022, then surged by 98.37% to -$227000.0 in 2023, then sank by 225.11% to -$738000.0 in 2024, then slumped by 736.72% to -$6.2 million in 2025.
- Business Quant data shows CELU's Enterprise Value at -$6.2 million in Q4 2025, -$120000.0 in Q3 2025, and -$863000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | -6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.18 Mn |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -863,000.00 |
| Mar 31, 2025 | -293,000.00 |
| Dec 31, 2024 | -738,000.00 |
| Sep 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -467,000.00 |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | -227,000.00 |
| Sep 30, 2023 | -273,000.00 |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | -8.53 Mn |
| Dec 31, 2022 | -13.97 Mn |
| Sep 30, 2022 | -42.65 Mn |
| Jun 30, 2022 | -38.00 Mn |
| Mar 31, 2022 | -48.04 Mn |
| Dec 31, 2021 | -37.24 Mn |
| Sep 30, 2021 | -73.31 Mn |
| Jun 30, 2021 | -211.00 |
| Mar 31, 2021 | -28,654.00 |